Novel PCSK9 inhibitor cut LDL cholesterol levels by more than half
byAmerican College of CardiologyCredit: Pixabay/CC0 Public DomainAmong patients at high or very high risk for a heart attack or stroke, the addition of the investigational drug lerodalcibep to s
Novel PCSK9 inhibitor cut LDL cholesterol levels by more than half
byAmerican College of CardiologyCredit: Pixabay/CC0 Public DomainAmong patients at high or very high risk for a heart attack or stroke, the addition of the investigational drug lerodalcibep to s